By inviting participants with an f-Hb concentration just below the cut-off (> 15–46.9 μg Hb/g feces) at a shorter interval, it is expected that, compared to uniform CRC screening, slightly more people will test false positive compared to true positives. This evidence concerns the gene GSTM1 and colorectal carcinoma.